Scinai Immunotherapeutics Ltd.
Nasdaq: SCNIBiological Products, (No Diagnostic Substances) · Entity-resolved by Clous
CIK0001611747
TickerSCNI
ExchangeNasdaq
SIC2836
StateL3
FY end12-31
Illustrative profile — live data lights up when a server API key is configured.
Key financials
Revenue
—
—
Net IncomeFY2022-12-31
-$5.8M
—
Total AssetsFY2022-12-31
$27.07M
—
EquityFY2022-12-31
-$1.76M
—
Shares OutstandingFY2022-12-31
1.31B
—
Operating Cash FlowFY2022-12-31
-$7.27M
—
Short interest & fails
Cost to borrow127.12%200K shares availablehard to borrow
Fails-to-deliver
SEC CNS fails · semi-monthly16.22K
shares failed · 2026-05-26
2026-05-2616.22K sh$0.46
2026-05-22100.24K sh$0.50
2026-05-21144.72K sh$0.48
2026-05-2048.8K sh$0.51
2026-05-1927.96K sh$0.56
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
| Concept | FY2022-12-31 | YoY | % rev |
|---|---|---|---|
| Net Income | -$5.8M | — | — |
| Total Assets | $27.07M | — | — |
| Equity | -$1.76M | — | — |
| Operating Cash Flow | -$7.27M | — | — |
| Shares Outstanding | 1.31B | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0001611747